Abstract
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the safety and efficacy of repetitive transcranial magnetic stimulation (rTMS) for the treatment of post-traumatic stress disorder (PTSD) in adults.
| Original language | English |
|---|---|
| Article number | CD015040 |
| Journal | The Cochrane database of systematic reviews |
| Volume | 2022 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 7 Jan 2022 |
| Externally published | Yes |
Bibliographical note
Funding Information:The authors thank the Cochrane Methods Support Unit for consultation support regarding choice of pairwise random-effects model for meta-analysis. Cochrane Common Mental Disorders (CCMD) supported the authors in the development of this protocol. The following people conducted the editorial process for this article. Sign-off Editor (final editorial decision): Nick Meader, CCMD, Centre for Reviews and Dissemination, University of York Managing Editor (selected peer reviewers, collated peer-reviewer comments, provided editorial guidance to authors, edited the article): Jessica Hendon, CCMD, Centre for Reviews and Dissemination, University of York Information Specialist (developed the search strategy in consultation with review authors, provided editorial guidance to authors, edited the article): Sarah Dawson, CCMD and University of Bristol Peer reviewers (provided comments and recommended an editorial decision): Andrew Leuchter, Department of Psychiatry and Biobehavioral Sciences, and Neuromodulation Division, Semel Institute for Neuroscience and Human Behavior, UCLA (clinical/content review); Jean Sellar-Edmunds, York (consumer review);?Rachel Richardson, Associate Editor, Cochrane (methods review). Copy Editor (copy-editing and production): Faith Armitage The authors and the CCMD Editorial Team are grateful to the peer reviewers for their time and comments. They would also like to thank Cochrane Copy Edit Support for the team's help. Cochrane Group funding acknowledgement: the UK National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Common Mental Disorders Group. Disclaimer: the views and opinions expressed herein are those of the review authors and do not necessarily reflect those of the NIHR, National Health Service (NHS), or the Department of Health and Social Care.
Publisher Copyright:
Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.